Emerging Company Profile
Araris: universal linkers for antibody-drug conjugates
Emerging Company Profile: Swiss newco is developing peptide linkers that could improve ADC’s therapeutic window
Swiss start-up Araris is developing peptide linkers that could improve the therapeutic window and manufacturing of antibody-drug conjugates.
Mar 6, 2021 | 2:11 AM GMT
Araris is developing antibody-drug conjugate linker technology that could widen the therapeutic